ADC Therapeutics SA annual shares outstanding
2017
2018
2019
2020
2022
2023
2024
2025
ADC Therapeutics SA Shares Outstanding History (ADCT)
ADC Therapeutics SA reported 125.7M shares outstanding at the end of fiscal 2025.
View full ADC Therapeutics SA company overviewADC Therapeutics SA annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 125.7M | 26.9M | +27.20% |
| 2024 | 2024-12-31 | 98.9M | 16.6M | +20.13% |
| 2023 | 2023-12-31 | 82.3M | 1.7M | +2.05% |
| 2022 | 2022-12-31 | 80.6M | 3.9M | +5.11% |
| 2020 | 2020-12-31 | 76.7M | 24.6M | +47.27% |
| 2019 | 2019-12-31 | 52.1M | 4.3M | +8.93% |
| 2018 | 2018-12-31 | 47.8M | 450,000 | +0.95% |
| 2017 | 2017-12-31 | 47.4M | — | — |
ADC Therapeutics SA quarterly shares outstanding
Q4.17
Q4.18
Q4.19
Q4.20
Q4.22
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 127.4M | 14.9M | +13.28% |
| Q1 2026 | 2026-03-31 | 127.2M | 28.0M | +28.22% |
| Q4 2025 | 2025-12-31 | 125.7M | 26.9M | +27.20% |
| Q3 2025 | 2025-09-30 | 112.6M | 15.9M | +16.48% |
| Q2 2025 | 2025-06-30 | 112.5M | 16.0M | +16.62% |
| Q1 2025 | 2025-03-31 | 99.2M | 16.4M | +19.81% |
| Q4 2024 | 2024-12-31 | 98.9M | 16.6M | +20.13% |
| Q3 2024 | 2024-09-30 | 96.7M | 16.0M | +19.90% |
| Q2 2024 | 2024-06-30 | 96.5M | 19.7M | +25.74% |
| Q1 2024 | 2024-03-31 | 82.8M | 30.7M | +58.89% |
| Q4 2023 | 2023-12-31 | 82.3M | 34.5M | +72.07% |
| Q4 2022 | 2022-12-31 | 80.6M | 33.3M | +70.22% |
| Q4 2020 | 2020-12-31 | 76.7M | — | — |
| Q4 2019 | 2019-12-31 | 52.1M | — | — |
| Q4 2018 | 2018-12-31 | 47.8M | — | — |
| Q4 2017 | 2017-12-31 | 47.4M | — | — |
ADC Therapeutics SA shares outstanding trends
Over the last five reported fiscal years, ADC Therapeutics SA's shares outstanding moved from 52.1M to 125.7M, a change of 73.7M. The latest reported quarter, Q2 2026, shows 127.4M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ADC Therapeutics SA filings at SEC.gov ↗